Abstract
Despite significant gains and successes in many areas, progress in HIV prevention and treatment is uneven, highlighted in the 2022 UNAIDS report In Danger, and certain populations are being left behind. In particular, men and adolescent girls and young women (AGYW) are among the groups in danger of not reaching epidemic control targets. Among other calls for utilizing scientific innovations, PEPFAR’s Office of the Global AIDS Coordinator and Health Diplomacy recently highlighted the need to expand the use of innovative methods from behavioral science in HIV programs. One of these innovative, but underused, approaches is behavioral economics (BE), which leverages our predictable cognitive biases and mental shortcuts to both diagnose behavioral factors and positively influence behavior. The tools used by BE to change behavior are frequently called nudges, which tend to be low-cost and easy-to-implement interventions. This scoping review identified nudges applied to select client and provider behaviors along the HIV prevention, testing, and care and treatment continuum. It maps them to the commonly used EAST Framework, a simplified way to classify nudges for program design and highlights those that shifted behavior. The EAST Framework groups nudges into Easy, Attractive, Social, and Timely categories. This scoping review identified that Easy nudges were commonly applied as changes to the structure of HIV programs, influencing individual behavior through program changes. Nudges that directly targeted individuals most commonly fell into the Attractive and Social categories. Many of the individual-focused nudges in the Attractive and Social categories changed behavior, along with Easy nudges. Additionally, the mapping highlighted the dearth of nudges applied to provider behavior in the Low and Middle Income (LMIC) HIV space. Further integration of nudges into HIV programs and their evaluation using implementation science may help move the needle to end the HIV epidemic as a public health threat by 2030.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Disclaimer The contents in this article are those of the authors and do not necessarily reflect the view of the U.S. President’s Emergency Plan for AIDS Relief or the U.S. Agency for International Development or the U.S. Government
↵1 Senior Behavioral Scientist, USAID Bureau for Global Health Office of HIV/AIDS; USAID Consultant through Global Health Technical Assistance and Mission Support (GH-TAMS) Project
↵2 Senior Technical Advisor - Social and Behavior Change, USAID Bureau for Global Health Office of HIV/AIDS; USAID Contractor through SHTASC – Credence Management Solutions LLC
Data Availability
All data produce in the present work are contained in the manuscript.
